PD-1 deficiency reveals various tissue-specific autoimmunity by H-2band dose-dependent requirement of H-2g7for diabetes in NOD mice
- 4 March 2008
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 105 (9) , 3533-3538
- https://doi.org/10.1073/pnas.0710951105
Abstract
Although many autoimmune diseases are associated with particular HLA/H-2 haplotypes, the mechanisms through which specific HLA/H-2 haplotypes afford autoimmune susceptibility remain enigmatic. Here, we analyzed the effects of the diabetes-associated (H-2(g7)) and an antidiabetogenic (H-2(b)) H-2 haplotypes in NOD mice deficient for programmed cell death-1 (PD-1, Pdcd1), a unique model of type 1 diabetes that confers complete penetrance and rapid onset of the disease. NOD-H2(b/b)Pdcd1(-/-) mice were completely protected from diabetes, confirming that H-2(g7) is indispensable for diabetes even in the absence of PD-1. However, NOD-H2(b/b)Pdcd1(-/-) mice developed autoimmune inflammation in multiple tissues including peripheral nerves, stomachs, and exocrine tissues, demonstrating that autoreactive T cells are generated in the context of H-2(b). These autoreactive T cells damaged target tissues only in the absence of PD-1, confirming that PD-1 deficiency unravels the hidden autoimmune susceptibility of the strain by reducing the threshold of T cell activation. Transfer experiments revealed that CD4 T cells are the effector cells of neuritis, and nerve-infiltrating CD4 T cells are strongly deviated toward Th1. Interestingly, neuritogenic T cells were also generated in the context of H-2(g7), in sharp contrast to the strict requirement of H-2(g7) for diabetes. In addition, 60% of the NOD-H2(b/g7)Pdcd1(-/-) mice developed diabetes, suggesting that H-2(b) does not dominantly suppress diabetes and that H-2(g7) induces diabetes in a dose-dependent fashion.Keywords
This publication has 36 references indexed in Scilit:
- Interaction between B7-H1 and PD-1 determines initiation and reversal of T-cell anergyBlood, 2007
- Insulin-induced remission in new-onset NOD mice is maintained by the PD-1–PD-L1 pathwayThe Journal of Experimental Medicine, 2006
- Tissue expression of PD-L1 mediates peripheral T cell toleranceThe Journal of Experimental Medicine, 2006
- THE NOD MOUSE: A Model of Immune DysregulationAnnual Review of Immunology, 2005
- Failure to Censor Forbidden Clones of CD4 T Cells in Autoimmune DiabetesThe Journal of Experimental Medicine, 2002
- Development of Spontaneous Autoimmune Peripheral Polyneuropathy in B7-2–Deficient Nod MiceThe Journal of Experimental Medicine, 2001
- A Mechanism for the Major Histocompatibility Complex–linked Resistance to AutoimmunityThe Journal of Experimental Medicine, 1997
- Genetic Control of Autoimmune Diabetes in the Nod MouseAnnual Review of Immunology, 1995
- Following a diabetogenic T cell from genesis through pathogenesisCell, 1993
- Autoimmune syndromes in major histocompatibility complex (MHC) congenic strains of nonobese diabetic (NOD) mice. The NOD MHC is dominant for insulitis and cyclophosphamide-induced diabetes.The Journal of Experimental Medicine, 1992